Shares of Co-Diagnostics Inc (NASDAQ:CODX) saw an uptick in trading volume on Thursday . 713,225 shares were traded during trading, an increase of 2% from the previous session’s volume of 698,143 shares.The stock last traded at $1.17 and had previously closed at $1.01.
Several research firms recently issued reports on CODX. HC Wainwright began coverage on Co-Diagnostics in a research report on Monday, March 11th. They set a “buy” rating and a $2.00 price target on the stock. Maxim Group began coverage on Co-Diagnostics in a research report on Tuesday, April 9th. They set a “buy” rating and a $2.00 price target on the stock.
A hedge fund recently raised its stake in Co-Diagnostics stock. Vanguard Group Inc lifted its position in shares of Co-Diagnostics Inc (NASDAQ:CODX) by 18.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 95,342 shares of the company’s stock after purchasing an additional 15,027 shares during the period. Vanguard Group Inc’s holdings in Co-Diagnostics were worth $251,000 as of its most recent filing with the Securities and Exchange Commission. 1.43% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This report was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://transcriptdaily.com/2019/05/11/co-diagnostics-codx-sees-strong-trading-volume.html.
About Co-Diagnostics (NASDAQ:CODX)
Co-Diagnostics, Inc, a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc was founded in 2013 and is headquartered in Salt Lake City, Utah.
Featured Story: Why is momentum important to successful trading?
Receive News & Ratings for Co-Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Co-Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.